NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$5.50
+3.19%
Mkt Cap $24.71M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
Implied Upside
+263.6%
Consensus $20.00 vs current $5.50
NASDAQ·Healthcare·Biotechnology
$5.50
+3.19%
Mkt Cap $24.71M
No recent rating data.
Price Target (4 analysts)
$20.00
Range $20.00 – $20.00
+263.6%
Consensus $20.00 vs current $5.50